Marché mondial du traitement de la maladie de Paget – Tendances et prévisions de l’industrie jusqu’en 2028

Analyse et perspectives du marché : marché mondial du traitement de la maladie de Paget

Le marché du traitement de la maladie de Paget devrait connaître une croissance potentielle de 3,25 % au cours de la période de prévision de 2021 à 2028. L'augmentation de la population gériatrique est le facteur essentiel qui accélère la croissance du marché du traitement de la maladie de Paget.

La maladie de Paget est définie comme une maladie dans laquelle la fonction normale de remodelage de l'os par élimination de l'ancien matériau osseux est perdue. La maladie de Paget ne présente pas de symptômes clairs et les personnes qui en souffrent n'en sont souvent pas conscientes. Le traitement de la maladie de Paget est utilisé sur le crâne de la jambe affectée, les os, la colonne vertébrale ou le bassin et les radiographies sont utilisées comme diagnostic de la maladie.

L'augmentation des programmes de sensibilisation du gouvernement sur la maladie stimulera la croissance du marché, tout comme l'augmentation de la prévalence des maladies, l'augmentation de l' accessibilité des soins de santé aux États-Unis et l'augmentation des connaissances et de la sensibilisation de la population. Ces facteurs sont essentiels, entre autres, pour stimuler la croissance du marché du traitement de la maladie de Paget. De plus, l'augmentation des activités de recherche et développement sur le marché et l'augmentation de la demande des économies émergentes créeront de nouvelles opportunités pour le marché du traitement de la maladie de Paget au cours de la période de prévision 2021-2028.

Cependant, l'augmentation du coût de la recherche et du développement sur le marché constitue un facteur majeur parmi d'autres agissant comme une contrainte, et constituera un défi supplémentaire pour le marché du traitement de la maladie de Paget au cours de la période de prévision mentionnée ci-dessus.

Paget's disease treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the paget's disease treatment market scenario contact Data bridge market research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Paget's Disease Treatment Market Scope and Market Size

Paget's disease treatment market is segmented on the basis of route of administration, treatment type, distribution channel and drug-class. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of route of adminstration, paget's disease treatment market is segmented into oral, intravenous and topical.
• Based on treatment type, paget's disease treatment market is segmented into actonel, reclast, zoledronic acid, fosamax, miacalcin, aredia, calcitonin, zometa and others.
• Based on distribution channel, paget's disease treatment market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and drug stores.
• Paget's disease treatment market is also segmented on the basis of drug-class into bisphosphonates, calcitonin analogues, calcium supplements, vitamin-D supplements and analgesics.

Paget’s Disease Treatment Market Country Level Analysis

Paget's disease treatment market is analysed and market size information is provided by country, route of administration, treatment type, distribution channel and drug-class as referenced above.

The countries covered in the paget's disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the paget's disease treatment market due to rise in the prevalence of the diseases, rise in the healthcare affordability in the US and rise in the knowledge and awareness amongst the people in this region. Asia-Pacific is the expected region in terms of growth in paget's disease treatment market due to increase in the geriatric population base and the increase in the awareness level among consumers regarding rare orthopedic diseases and their treatment in this region.

The country section of the paget's disease treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Paget's disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Paget’s Disease Treatment Market Share Analysis

Paget's disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to osteoarthritic pain management treatment.

Les principaux acteurs couverts dans le rapport sur le marché du traitement de la maladie de Paget sont Pfizer Inc., AstraZeneca, Eli Lilly and Company, Abiogen Pharma SpA, Merck Sharp & Dohme Corp., Novartis AG, GlaxoSmithKline plc., Zimmer Biomet, Johnson & Johnson Private Limited, Sun Pharmaceutical Industries Ltd, Mallinckrodt, Fresenius Kabi, Sanofi et Mylan NV, entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché du traitement de la maladie de Paget sont disponibles séparément pour le monde, l'Amérique du Nord, l'Amérique du Sud, l'Europe, l'Asie-Pacifique (APAC) et le Moyen-Orient et l'Afrique (MEA). Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-63090